Last reviewed: June 18, 2026

Last updated: June 18, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide belongs to a class of medications called GLP-1 receptor agonists, originally developed to treat type 2 diabetes. Clinical trials show that higher-dose semaglutide injections can help patients lose up to 22% of their body weight over 68 weeks when paired with diet and exercise modifications.

What Is Semaglutide and How Does It Work

Semaglutide is a synthetic version of glucagon-like peptide-1 (GLP-1), a hormone your gut naturally produces when you eat. This medication binds to GLP-1 receptors in your brain, specifically in areas that control hunger, fullness signals, and blood sugar regulation. By activating these receptors, semaglutide slows how quickly food moves through your stomach and increases feelings of satiety, so you eat less without conscious restriction.

The medication also influences your body's energy use and fat storage pathways. Studies demonstrate that semaglutide users report reduced cravings for high-calorie foods and improved portion control within days to weeks of starting treatment. This neurological effect, combined with delayed gastric emptying, creates a dual mechanism that supports sustainable weight loss rather than temporary calorie restriction.

Clinical Evidence for Semaglutide Weight Loss Results

The STEP trials, published in major medical journals between 2021 and 2022, followed thousands of patients receiving semaglutide injections weekly for 68 weeks. Participants on the highest dose experienced an average 15% body weight reduction compared to just 2.6% in the placebo group. Approximately 50% of semaglutide users achieved at least 15% weight loss, and many continued losing weight into year two of treatment.

Beyond weight loss numbers, clinical data shows semaglutide improves cardiovascular risk markers including blood pressure, cholesterol levels, and blood sugar control independent of weight reduction. Patients also report improved mobility, reduced joint pain, and better sleep quality—benefits tied to both weight loss and the medication's direct effects on metabolic pathways. Real-world data from specialty weight loss clinics mirrors trial outcomes when patients commit to consistent dosing and lifestyle support.

Semaglutide Injection vs. Oral Forms and Other GLP-1 Options

Injectable semaglutide delivers medication directly into the bloodstream through subcutaneous injection once weekly, achieving higher blood levels and often faster results compared to daily oral tablets. PlexusDx offers compounded semaglutide injections starting at $149 per month, making weekly injections accessible without insurance. Oral semaglutide requires daily dosing and higher pill counts to achieve similar efficacy, priced at $249 per month through PlexusDx.

Some patients prefer oral formulations due to injection anxiety or convenience, while others achieve superior appetite control with injections. PlexusDx also offers tirzepatide (a dual GLP-1 and GIP receptor agonist) and combination therapies for patients who plateau on semaglutide alone. Your personalized response depends on genetic factors, baseline metabolism, and individual appetite-regulation pathways—areas where PlexusDx Precision Peptide Genetic Testing provides objective insight.

Getting Started With Compounded Semaglutide at PlexusDx

PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies in all 50 states, requiring no insurance, membership fees, or prior authorizations. Your initial consultation includes medical history review, metabolic assessment, and a discussion of realistic timeline and expectations. Most patients begin at a low dose to assess tolerability, then gradually increase over 4-8 weeks until reaching their therapeutic dose—a process called titration.

Your dose may increase based on clinical response and tolerance. Your price won't. All compounded semaglutide injections remain flat-rate at $149-$189 per month across commitment tiers, regardless of final dose level. HSA and FSA accounts cover PlexusDx medications, and ongoing medication management includes check-ins, side effect monitoring, and adjustments to maximize your weight loss while minimizing discomfort. Optional Precision Peptide Genetic Testing ($99 add-on after your first month) identifies how your unique genetic variants in GLP1R, FTO, MC4R, and GIPR pathways influence your treatment response.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I see weight loss results with semaglutide injections?

Most patients notice reduced appetite within 3-7 days of their first injection, with measurable weight loss appearing within 2-4 weeks. Average weight loss accelerates through weeks 4-12 as your body adjusts and your dose reaches therapeutic levels. Clinical trials show the greatest monthly losses occur between weeks 8-20, with continued gradual loss through month 12 and beyond.

Does semaglutide work for everyone, or do some people not respond?

Clinical data shows approximately 67% of semaglutide users achieve at least 5% body weight loss, while about 33% achieve less than 5% loss. Non-response or poor response may relate to genetic variants affecting GLP-1 receptor function, baseline metabolism, medication adherence, or inadequate lifestyle support. PlexusDx Precision Peptide Genetic Testing identifies your GLP1R and other appetite-control variants to predict responsiveness before you commit to long-term therapy.

What is the cost of semaglutide at PlexusDx compared to brand-name Wegovy?

PlexusDx compounded semaglutide injections start at $149 per month through licensed 503A pharmacies, while brand-name Wegovy typically costs $900-$1,500 monthly without insurance. PlexusDx requires no insurance, membership, or prior authorization, and HSA/FSA benefits apply. Your price remains flat across all dose increases—no step-up pricing tiers.

What are the most common side effects, and are they permanent?

Nausea, vomiting, constipation, and diarrhea occur in 20-50% of users, usually during dose escalation and typically resolve within 1-2 weeks as your body adapts. Appetite suppression is intentional and beneficial. Rare serious side effects include pancreatitis or thyroid concerns, monitored through periodic check-ins with your PlexusDx provider. Side effects are not permanent—they diminish or disappear once your dose stabilizes or if treatment stops.

Does PlexusDx genetic testing tell me if semaglutide will work for my weight loss?

PlexusDx Precision Peptide Genetic Testing ($99 add-on) maps 14 metabolic pathways and identifies your variants in GLP1R, GIPR, FTO, and MC4R genes—all linked to appetite regulation and weight loss potential. This test predicts how your body uses and responds to semaglutide and other GLP-1 therapies, helping your provider optimize your medication choice and dosing strategy before investing months in a suboptimal treatment.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves